Vanta Bioscience Quarterly Results for Trading Insights
VANTABIO • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QMar 2023
Vanta Bioscience Quarterly Results Key Highlights
- Revenue of ₹1 Cr in Mar 2023 (-80.0% vs Mar 2022, -80.0% vs Mar 2022)
- Net Profit of ₹-1 Cr in Mar 2023
- EBITDA of ₹-1 Cr in Mar 2023 (-150.0% vs Mar 2022)
- Operating Margin of -206.0% in Mar 2023 (-252.0pp vs Mar 2022)
Vanta Bioscience Quarterly Results Analysis
| Metric | Mar 2023 | Mar 2022 | Dec 2022 | Dec 2021 | QoQ | YoY |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 1 | 5 | 3 | 0 | -80.0% | -80.0% |
| Net Profit (₹ Cr) | -1 | 0 | -3 | 0 | - | - |
| EBITDA (₹ Cr) | -1 | 2 | -1 | 0 | - | - |
| EPS (₹) | 0.00 | 0.11 | -4.06 | 0.00 | - | - |
| Operating Margin (%) | -206.0% | 46.0% | -20.0% | 0.0% | - | - |
Vanta Bioscience Share Price Trend Around Quarterly Results
Visualize Vanta Bioscience's 1-year price movement across quarterly results — ideal for logging trades in Vanta Bioscience share price
chart using Tickjournal. All values in ₹.
Related Pages for Vanta Bioscience
Additional stock information and data for VANTABIO
Revenue Trend (₹ Cr)
Dec 2021
0
Dec 2022
3
Mar 2022
5
Mar 2023
1
Net Profit Trend (₹ Cr)
Dec 2021
0
Dec 2022
-3
Mar 2022
0
Mar 2023
-1
Operating Margin Trend (%)
Dec 2021
0.0%
Dec 2022
-20.0%
Mar 2022
46.0%
Mar 2023
-206.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Vanta Bioscience quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹422,330.94 Cr | 1760.2 | 14,875 | 3,125 | +10.8% | - | 21.0% | 135.4 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6642.5 | 2,860 | 689 | +7.1% | - | 24.1% | 255.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3936.8 | 3,219 | 591 | +11.3% | - | 18.4% | 224.4 |
|
Cipla
Sept 2025 |
₹121,238.47 Cr | 1530.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 91.5 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1256.2 | 9,135 | 1,337 | +1.1% | - | 14.6% | 77.6 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores